Ownership history in Graypoint LLC · 11 quarters on record
This page tracks every 13F SEC filing in which Graypoint LLC reported a position in SPDR S&P BIOTECH ETF (XBI). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q1 | ADDED | 2,771 | +1 | +0.0% | 0.01% | $225K | $80.80 |
| 2024 Q4 | ADDED | 2,770 | +32 | +1.2% | 0.02% | $250K | $89.72 |
| 2024 Q3 | ADDED | 2,738 | +146 | +5.6% | 0.02% | $271K | $98.43 |
| 2024 Q2 | ADDED | 2,592 | +22 | +0.9% | 0.02% | $240K | $92.35 |
| 2024 Q1 | REDUCED | 2,570 | -1,019 | -28.4% | 0.02% | $244K | $94.40 |
| 2023 Q2 | ADDED | 3,589 | +142 | +4.1% | 0.03% | $299K | $82.76 |
| 2023 Q1 | ADDED | 3,447 | +231 | +7.2% | 0.03% | $263K | $75.80 |
| 2022 Q4 | ADDED | 3,216 | +79 | +2.5% | 0.03% | $267K | $82.56 |
| 2022 Q3 | ADDED | 3,137 | +58 | +1.9% | 0.03% | $249K | $78.90 |
| 2022 Q2 | REDUCED | 3,079 | -100 | -3.1% | 0.03% | $229K | $73.87 |
As of 2025 Q4 — sorted by position size